AbCellera Biologics Inc.
ABCL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703057
In the last 90 days, AbCellera Biologics Inc. insiders filed 4 open-market purchases and 0 sales; 150 institutions reported holding it in 13F filings for Q2 2026, worth $908.8M in total; no superinvestor holds it.
Members of Congress who traded ABCL
No member of Congress has reported a trade in AbCellera Biologics Inc. since 2020.
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.